Fetterman appealed to President Trump and Health and Human Services Secretary Robert F. Kennedy Jr. personally.

The Trump administration canceled a Biden-era plan on Friday that would have made Ozempic and other weight-loss drugs available on Medicare and Medicaid and expanded access to them for millions of Ame ...

In a New York Times column this week, the Pennsylvania Democrat shared his experience taking Mounjaro while advocating for ...

Medicare Advantage updates while halting proposed anti-obesity drug coverage, impacting millions of potential beneficiaries.

The CMS has opted not to move forward with a plan that would have extended Medicare coverage to obesity drugs for millions of ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

The Trump administration announced Friday it will not move forward with plans to cover popular weight-loss drugs under ...

Donald Trump’s team gutted the Biden administration’s plan as part of a sprawling 438-page regulation update that tweaks how beneficiaries get drug coverage ...

Proponents of coverage argued treating obesity can reduce longer-term costs by cutting down on heart attacks and other health ...

As counterfeit Ozempic circulates in the U.S., the Food and Drug Administration has issued a warning to Americans. In an April 14 announcement, the FDA stated that Novo Nordisk — manufacturer of ...